Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500 GMT/11 AM ET

Thu, 19th Apr 2018 16:23

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Allergan moves in as Shire rebuffs $63 bln Takeda bid-sources

LONDON/NEW YORK - Drugmaker Shire has rejected a thirdtakeover bid worth nearly $63 billion from Japan's TakedaPharmaceutical, although talks are continuing, while sources sayAllergan is also in competing negotiations. (SHIRE-M&A/TAKEDAPHARMA-BID (UPDATE 2), moved, by Greg Roumeliotis, Ben Hirschlerand Ben Martin, 550 words)

EXCLUSIVE-China looks to speed up chip plans as U.S. tradetensions boil -sources

BEIJING - China is looking to accelerate plans to developits domestic semiconductor market amid a fierce trade stand-offwith the United States and a U.S. ban on sales to Chinese phonemaker ZTE that has underscored the country's reliance onimported chips. (USA-TRADE/CHINA-CHIPS (EXCLUSIVE), moved, byElias Glenn and Cate Cadell, 600 words)

P&G to buy German Merck's consumer health unit for $4.2 bln

Procter & Gamble Co will acquire the consumer healthbusiness of Merck KGaA for $4.2 billion, giving it vitaminbrands such as Seven Seas and greater exposure to Latin Americanand Asian markets. (MERCK-M&A/P&G (UPDATE 3, PIX), moved, 450words)

MARKETS

Apple, P&G and chip stocks lead Wall St lower

U.S. stock are lower, pulled down by a broad-based slump intechnology stocks from Apple to chipmakers as well as a tumblein consumer staples such as Procter & Gamble. (USA-STOCKS/(UPDATE 3), updated throughout the day, 420 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 4, PIX), updated throughout theday, 830 words

Oil climbs on Saudi price ambitions and U.S. stocks draw

LONDON - Oil prices keep rising to their highest since late2014 as U.S. crude inventories decline, moving closer tofive-year averages, and after sources tell Reuters that topexporter Saudi Arabia aims to push prices even higher.(GLOBAL-OIL/ (UPDATE 7, PIX), updated throughout the day, 430words)

TRADE/ECONOMY

U.S. weekly jobless claims dip in latest week

WASHINGTON - New applications for U.S. unemployment benefitsfell last week, indicating continued job growth after a slowdownin March. (USA-ECONOMY/UNEMPLOYMENT, moved, 340 words)

China says ready to deal with any fallout from U.S. traderow

BEIJING - China is well prepared to handle any negativeeffects from its trade dispute with the United States, thecommerce ministry says, adding that Beijing's tariff hikes onU.S. imports will not have a big impact overall on its domesticindustries. (USA-TRADE/CHINA (WRAPUP 1, TV), moved, by YawenChen and Se Young Lee, 490 words)

Trump, Japan's Abe agree to intensify trade talks

PALM BEACH - U.S. President Donald Trump and Japanese PrimeMinister Shinzo Abe say they have agreed to intensify tradeconsultations between the two longtime allies, with an aim toexpand investment and trade between their countries.(USA-JAPAN/TRADE-IMBALANCES (UPDATE 3), moved, by Steve Holland,500 words)

COMPANIES

As Bon-Ton liquidates, U.S. department stores vie for itsshoppers

With the disappearance of Bon-Ton, which won courtpermission on Wednesday to liquidate, rivals such as Macy's Inc,J.C. Penney Co Inc and Kohls Corp will compete to keep longtimecustomers from turning to discounters like Walmart Inc or onlinejuggernaut Amazon.com Inc. (BON TON STORES-BANKRUPTCY/ (REPEAT),moved, by Tracy Rucinski and Melissa Fares, 480 words)

Nucor profit beats estimates on higher prices, shipments

Nucor Corp reported a higher-than-expected quarterly profitas its shipments and selling price increased, and the company,the No. 1 U.S. steelmaker by market value, forecast asignificant increase in second-quarter profit on a sequentialbasis. (NUCOR-RESULTS/ (UPDATE 1), moved, 210 words)

Market swings knock Blackstone earnings less than feared

Blackstone Group LP, the largest manager of alternativeassets such as private equity and real estate, on Thursdayreported a 20 percent drop in first-quarter earnings per sharebut still beat Wall Street's expectations, as a stock marketslump weighed on the value of its holdings. (BLACKSTONEGROUP-RESULTS/ (UPDATE 1), moved, by Joshua Franklin, 360 words)

China's ZTE removed chief compliance officer before U.S.sanction -source

HONG KONG - ZTE Corp's chief compliance and chief legalofficer was removed from his posts more than a month before theChinese telecom equipment maker was slapped with U.S. sanctionsthis week, a company source with direct knowledge of thesituation told Reuters. (USA-CHINA/ZTE (PIX), moved, by SijiaJiang, 370 words)

+ See also:

- USA-CHINA/ZTE-RIVALS, moved, by Olof Swahnberg and EricAuchard, 770 words

EXCLUSIVE-Facebook to put 1.5 billion users out of reach ofnew EU privacy law

SAN FRANCISCO - If a new European law restricting whatcompanies can do with people's online data went into effecttomorrow, almost 1.9 billion Facebook Inc users around the worldwould be protected by it. The online social network is makingchanges that ensure the number will be much smaller.(FACEBOOK-PRIVACY/EU (UPDATE 1, EXCLUSIVE, PIX), moved, by DavidIngram, 750 words)

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH - Swiss drugmaker Novartis' first quarterly resultsunder new Chief Executive Vas Narasimhan have been marred by aprized psoriasis treatment that disappointed and a sharp slumpin sales by its U.S. generics unit. (NOVARTIS-RESULTS/ (UPDATE4, PIX), moved, by John Miller, 610 words)

More News
30 Nov 2018 07:38

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE is

Read more
30 Nov 2018 07:23

Shire gets EC approval for hereditary angioedema jab

(Sharecast News) - Shire's injectable treatment for hereditary angioedema (HAE) has been cleared for launch in European, having enjoyed early success in the US.

Read more
28 Nov 2018 07:53

Shire's Lanadelumab Help Study Meets Primary And Secondary Endpoints

LONDON (Alliance News) - Shire PLC said Tuesday it has published the full results of its phase III Help study of its hereditary angioedema drug Lanadelumab showing that the study met all of its is

Read more
20 Nov 2018 14:34

EU clears Takeda's Shire acquisition on divestment condition

(Sharecast News) - The European Commission has cleared Takeda Pharmaceutical's £46bn acquisition of Shire, subject to the divestment of a bowel disease drug under development by Shire.

Read more
1 Nov 2018 12:48

TOP NEWS: Shire Revenue Climbs On Strong Performance From Immunology

LONDON (Alliance News) - Shire PLC on Thursday updated its guidance and said its revenue grew in the third quarter of of 2018 as a result of strong Immunology division growth, recent product and a

Read more
1 Nov 2018 12:09

Shire sales remain solid, Takeda deal 'on track'

(Sharecast News) - Shire Pharmaceuticals, the subject of a $62bn takeover by Japan's Takeda, said its focus on rare diseases had offset foreign exchange weakness and boosted third-quarter profits.

Read more
1 Nov 2018 08:48

LONDON MARKET OPEN: Oil Stocks And Strong Pound Weigh On FTSE 100

LONDON (Alliance News) - Stocks in London opened mixed on Thursday, with heavyweight oil majors and a stronger pound hampering the FTSE 100, ahead of the Bank of England's interest rate decion

Read more
31 Oct 2018 06:11

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen. That compares with an earlier company estimate of yen an

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 07:35

LONDON MARKET PRE-OPEN: Better-Than-Expected HSBC To Lift FTSE 100

LONDON (Alliance News) - Stocks in London are set to open on firmer ground on Monday, following last week's sell-off, while traders eye Chancellor Philip Hammond's UK government shares in in

Read more
26 Oct 2018 07:52

Takeda Secures JPY1 Trillion Of Financing To Help Shire Deal

LONDON (Alliance News) - Japan's Takeda Pharmaceuticals Inc on Friday said it has secured new financing to help it with its acquisition of FTSE 100 member Shire PLC.The new short-term a

Read more
25 Oct 2018 16:21

Shire hopes to get green light for US Flexbumin manufacture

(Sharecast News) - Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.

Read more
25 Oct 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.